(Q37774352)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

review article

1 reference

title

Should prostate-specific antigen screening be offered to asymptomatic men? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Heidi A van Vugt

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Chris H Bangma

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

1043-1053

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the cancer incidence and mortality in Europe in 2006.

8 February 2020

cites work

1 reference

21 January 2018

Cancer statistics, 2009

1 reference

Screening and prostate-cancer mortality in a randomized European study

21 January 2018

1 reference

Prostate cancer: genes, environment, immunity and the use of immunotherapy

21 January 2018

1 reference

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study

21 January 2018

1 reference

Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial

21 January 2018

1 reference

Mortality results from a randomized prostate-cancer screening trial

21 January 2018

1 reference

Part 1: The burden of prostate cancer, its natural history, information on the outcome of screening and estimates of ad hoc screening with particular reference to England and Wales

21 January 2018

1 reference

Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower

21 January 2018

1 reference

Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics.

21 January 2018

1 reference

Defining the optimal prostate-specific antigen threshold for the diagnosis of prostate cancer

21 January 2018

1 reference

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

21 January 2018

1 reference

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis

21 January 2018

1 reference

Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL.

21 January 2018

1 reference

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial

21 January 2018

1 reference

Characteristics of prostate cancer detected by digital rectal examination only

21 January 2018

1 reference

The role of the digital rectal examination in subsequent screening visits in the European randomized study of screening for prostate cancer (ERSPC), Rotterdam

21 January 2018

1 reference

Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies.

21 January 2018

1 reference

Biopsy standards for detection of prostate cancer

21 January 2018

1 reference

Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care

21 January 2018

1 reference

A framework for the identification of men at increased risk for prostate cancer.

21 January 2018

1 reference

Human prostate cancer risk factors

21 January 2018

1 reference

Defining increased future risk for prostate cancer: evidence from a population based screening cohort.

21 January 2018

1 reference

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review

21 January 2018

1 reference

A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.

21 January 2018

1 reference

Pathological outcomes of candidates for active surveillance of prostate cancer

21 January 2018

1 reference

Predictive models in diagnosing indolent cancer.

21 January 2018

1 reference

Role of nomograms for prostate cancer in 2007.

21 January 2018

1 reference

An updated catalog of prostate cancer predictive tools

21 January 2018

1 reference

Prostate cancer risk assessment: choosing the sharpest tool in the shed

21 January 2018

1 reference

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

21 January 2018

1 reference

Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.

21 January 2018

1 reference

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

21 January 2018

1 reference

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

21 January 2018

1 reference

Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.

21 January 2018

1 reference

Active surveillance for early-stage prostate cancer: review of the current literature

21 January 2018

1 reference

Active surveillance of early prostate cancer: rationale, initial results and future developments

21 January 2018

1 reference

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

21 January 2018

1 reference

Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study.

21 January 2018

1 reference

Prostate cancer diagnosis: the impact on patients' mental health.

21 January 2018

1 reference

Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer.

21 January 2018

1 reference

The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance.

21 January 2018

1 reference

Quality of life after radical prostatectomy or watchful waiting.

21 January 2018

1 reference

Anxiety and distress during active surveillance for early prostate cancer.

21 January 2018

1 reference

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

21 January 2018

1 reference

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study

21 January 2018

1 reference

Prostate specific antigen best practice statement: 2009 update.

21 January 2018

1 reference

Prostate specific antigen testing among the elderly--when to stop?

21 January 2018

1 reference

Outcomes of localized prostate cancer following conservative management

21 January 2018

1 reference

Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up

21 January 2018

1 reference

Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested

21 January 2018

1 reference

Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial

21 January 2018

1 reference

Imaging techniques for prostate cancer: implications for focal therapy

21 January 2018

1 reference

Overview of pivotal studies for prostate cancer risk reduction, past and present

21 January 2018

1 reference

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection

21 January 2018

1 reference

Pathologic characteristics of cancers detected in The Prostate Cancer Prevention Trial: implications for prostate cancer detection and chemoprevention

21 January 2018

1 reference

Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach

21 January 2018

1 reference

Cancer incidence and mortality in Europe, 2004

21 January 2018

1 reference

Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram

21 January 2018

1 reference

Nomogram use for the prediction of indolent prostate cancer

21 January 2018

1 reference

Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened P

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.10.64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20645694%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference